Clinical and Economic Considerations in the Treatment of Prostate Cancer
- 1 August 1994
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 6 (2) , 127-141
- https://doi.org/10.2165/00019053-199406020-00005
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Endocrine Therapy for Prostate Cancer: Recent Developments and Current StatusBritish Journal of Urology, 1993
- The cancer experience in the framingham heart study cohortCancer, 1991
- Cancer in the European community and its member statesEuropean Journal of Cancer and Clinical Oncology, 1990
- Costs and benefits of early detection of prostatic cancerHealth Policy, 1990
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Prevention of the Transient Adverse Effects of a Gonadotropin-Releasing Hormone Analogue (Buserelin) in Metastatic Prostatic Carcinoma by Administration of an Antiandrogen (Nilutamide)New England Journal of Medicine, 1989
- Cardiovascular follow‐up of patients with prostatic cancer treated with single‐drug polyestradiol phosphateThe Prostate, 1987
- Orchidectomy versus oestrogen for prostatic cancer: cardiovascular effects.BMJ, 1986
- Probabilities of Eventually Developing or Dying of Cancer--United States, 1985CA: A Cancer Journal for Clinicians, 1985
- International trends in prostatic cancerInternational Journal of Cancer, 1984